AstraZeneca PLC (AZN)

NYSE - NYSE Real Time Price. Currency in USD
31.00+0.22 (+0.71%)
At close: 4:02 PM EDT

30.76 -0.24 (-0.77%)
Pre-Market: 4:35 AM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close30.78
Bid30.91 x 1300
Ask30.93 x 2900
Day's Range30.76 - 31.14
52wk Range26.97 - 35.04
1y Target EstN/A
Market Cap80.32B
P/E Ratio (ttm)35.43
Avg Vol (3m)5,558,600
Dividend & Yield0.90 (2.93%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Forbes21 hours ago

    Cloud-Centered IT Transformation At AstraZeneca

    Now that AstraZeneca’s transition to the cloud is largely in place, it is seeing broad business benefits across the organization. Cloud-based solutions enabled AstraZeneca to implement work faster than legacy tools would have allowed. The company is also taking advantage of the efficiency of the cloud model, including a reduction in capital expenditure, the ability to scale up and down, and the fact that it needs fewer people to support apps like Workday or ServiceNow as compared to SAP.

  • Investopedia2 days ago

    Drug Wars: California Vote Could Limit Price Hikes

    Major drug companies have spent $60 million to defeat a referendum calling for price limits

  • AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted
    Zacks2 days ago

    AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted

    AstraZeneca plc (AZN) announced that the FDA has accepted for review its complete re-submission of the new drug application (NDA) for ZS-9 (sodium zirconium cyclosilicate).